亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠城科技發展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經營的生物化工、醫藥中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 氨芬酸鈉
氨芬酸鈉
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:43
 
詳細信息
氨芬酸鈉 
英文名稱: AAmfenac sodium ;Fenazox;
別名: 氨酚酸鈉
化學名:2-(2-氨基-3-苯甲酰苯基)乙酸鈉水合物 
英文名稱: AAmfenac sodium ;Fenazox;
CAS號: 61618-27-7 
分子式: C15H12NNaO3.H2O 
分子量: 295.27 
規格型號:99% 
外觀:白色或類白色結晶性粉末。
用途:本品具有消炎、鎮痛、解熱作用。作用機制是抑制
前列腺素生物合成,阻斷炎癥介質的作用。用于慢性類風
濕性關節炎、變形性關節炎 、腰痛、
肩周炎及手術后、外傷后的消炎鎮痛。 
包裝:25KG/桶
AAmfenac sodium; Fenazox;
Alias: Paracetamol and sodium
Chemical Name: 2 - (2 - amino -3-- benzoyl phenyl) acetate hydrate
English name: AAmfenac sodium; Fenazox;
CAS Number: 61618-27-7
Molecular formula: C15H12NNaO3.H2O
MW: 295.27
Packing: 25kg cardboard drum
Specification: 99%
Appearance: white or almost white crystalline powder.
Uses: This product has anti-inflammatory, analgesic, 
antipyretic effect. Mechanism of action is inhibition
 of prostaglandin biosynthesis, the role of blocking 
inflammatory mediators. For chronic rheumatoid arthritis,
 deformation of arthritis, back pain,
Frozen and after surgery, trauma after the anti-inflammatory analgesic.


 

©2025 武漢遠城科技發展有限公司銷售八部 版權所有   技術支持:化工網   訪問量:27714  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |